Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2013

01-02-2013 | Original Article

Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis

Authors: Takashi Takei, Mitsuyo Itabashi, Takahito Moriyama, Ari Shimizu, Yuki Tsuruta, Ayami Ochi, Kayu Nakayama, Chihiro Iwasaki, Keiko Uchida, Kosaku Nitta

Published in: Clinical and Experimental Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Pathogenesis and clinical prognosis of membranoproliferative glomerulonephritis (MPGN) has not yet been established.

Methods

We conducted a retrospective study of 41 patients with MPGN (type I and III) and examined the renal survival. In addition, factors contributing to survival time were analyzed.

Results

Fourteen patients (34 %) were classified into the renal death group. Patients with nephrotic syndrome and positive C1q staining of glomerular deposits showed a particularly poor prognosis. Significantly higher frequency of nephrotic syndrome and higher urinary protein excretion were observed in the renal death group (p = 0.0002, p = 0.0002) than in the renal survival group. The intensity of C1q staining was positively correlated with the severity of the proteinuria (p = 0.004). Factors that influenced the survival time were positive C1q staining of glomerular deposits (p = 0.003), presence of nephrotic syndrome (p = 0.004), serum albumin (p = 0.02), and proteinuria (p = 0.04).

Conclusions

C1q staining in glomerular deposits and nephrotic syndrome were important factors influencing the prognosis and outcome in MPGN patients. C1q deposition may play a key role in the pathogenesis of MPGN, as evidenced by numerous observations, such as induction of proteinuria.
Literature
1.
go back to reference Kher V, Gulati S. Mesangiocapillary glomerulonephritis. In: Davidson AM, editor. Oxford textbook of clinical nephrology. 3rd ed. Oxford: Oxford University Press; 2005. p. 523–45. Kher V, Gulati S. Mesangiocapillary glomerulonephritis. In: Davidson AM, editor. Oxford textbook of clinical nephrology. 3rd ed. Oxford: Oxford University Press; 2005. p. 523–45.
2.
3.
go back to reference Zhou XJ, Silva FG. Membranoproliferative glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG editors. Heptinstall’s pathology of the kidney, 6th edn. Philadelphia: Lippincott Williams and Wilkins; 2009, vol 1, pp 253–319. Zhou XJ, Silva FG. Membranoproliferative glomerulonephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG editors. Heptinstall’s pathology of the kidney, 6th edn. Philadelphia: Lippincott Williams and Wilkins; 2009, vol 1, pp 253–319.
4.
go back to reference Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. Am J Kidney Dis. 1987;9:115–20.PubMed Jackson EC, McAdams AJ, Strife CF, Forristal J, Welch TR, West CD. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation. Am J Kidney Dis. 1987;9:115–20.PubMed
5.
go back to reference Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6:494–9.PubMedCrossRef Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC. C3 glomerulopathy: a new classification. Nat Rev Nephrol. 2010;6:494–9.PubMedCrossRef
6.
go back to reference Habib R, Gubler MC, Loirat C, Mäiz HB, Levy M. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int. 1975;7:204–15.PubMedCrossRef Habib R, Gubler MC, Loirat C, Mäiz HB, Levy M. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int. 1975;7:204–15.PubMedCrossRef
7.
go back to reference Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, et al. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant. 2004;19:2769–77.PubMedCrossRef Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, et al. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant. 2004;19:2769–77.PubMedCrossRef
8.
go back to reference Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, et al. Clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol. 2008;19:2237–44.PubMedCrossRef Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, et al. Clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol. 2008;19:2237–44.PubMedCrossRef
9.
go back to reference Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis. 2000;35:E22.PubMedCrossRef Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis. 2000;35:E22.PubMedCrossRef
10.
go back to reference Davenport A, Maciver AG, Mackenzie JC. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant. 1992;7:391–6.PubMed Davenport A, Maciver AG, Mackenzie JC. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant. 1992;7:391–6.PubMed
11.
go back to reference Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol. 2008;3:1637–43.PubMedCrossRef Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol. 2008;3:1637–43.PubMedCrossRef
12.
go back to reference Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64:1232–40.PubMedCrossRef Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64:1232–40.PubMedCrossRef
13.
go back to reference Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Roccatello D, et al. Incidence of biopsy proven primary glomerulonephritis in an Italian province. Am J Kidney Dis. 1996;27:631–9.PubMedCrossRef Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Roccatello D, et al. Incidence of biopsy proven primary glomerulonephritis in an Italian province. Am J Kidney Dis. 1996;27:631–9.PubMedCrossRef
14.
go back to reference Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron. 1994;67:59–65.PubMedCrossRef Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron. 1994;67:59–65.PubMedCrossRef
15.
go back to reference Droz D, Noel LH, Barbanel C, Grünfeld JP. Long-term evolution of membranoproliferative glomerulonephritis in adults: spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases. Nephrologie. 1982;3:6–11.PubMed Droz D, Noel LH, Barbanel C, Grünfeld JP. Long-term evolution of membranoproliferative glomerulonephritis in adults: spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases. Nephrologie. 1982;3:6–11.PubMed
16.
go back to reference Bohle A, Wehrmann M, Bogenschütz O, Bogenschütz O, Batz C, Vogl W, et al. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract. 1992;188:908–24.PubMedCrossRef Bohle A, Wehrmann M, Bogenschütz O, Bogenschütz O, Batz C, Vogl W, et al. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract. 1992;188:908–24.PubMedCrossRef
17.
go back to reference Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron. 1990;55:242–50.PubMedCrossRef Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W. Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: an investigation of 220 cases. Nephron. 1990;55:242–50.PubMedCrossRef
18.
go back to reference Braun MC, West CD, Strife CF. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Am J Kidney Dis. 1999;34:1022–32.PubMedCrossRef Braun MC, West CD, Strife CF. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Am J Kidney Dis. 1999;34:1022–32.PubMedCrossRef
19.
go back to reference Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69:504–11.PubMedCrossRef Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69:504–11.PubMedCrossRef
20.
21.
go back to reference Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens. 2005;14:396–403.PubMedCrossRef Smith KD, Alpers CE. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens. 2005;14:396–403.PubMedCrossRef
22.
23.
go back to reference West CD, McAdams AJ. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase. Am J Kidney Dis. 1998;32:56–63.PubMedCrossRef West CD, McAdams AJ. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase. Am J Kidney Dis. 1998;32:56–63.PubMedCrossRef
24.
go back to reference Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20:2055–64.PubMedCrossRef Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20:2055–64.PubMedCrossRef
25.
go back to reference Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65:85–96.PubMedCrossRef Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65:85–96.PubMedCrossRef
26.
go back to reference Vikse BE, Bostad L, Aasarød K, Lysebo DE, Iversen BM. Prognostic factors in mesangioproliferative glomerulonephritis. Nephrol Dial Transplant. 2002;17:1603–13.PubMedCrossRef Vikse BE, Bostad L, Aasarød K, Lysebo DE, Iversen BM. Prognostic factors in mesangioproliferative glomerulonephritis. Nephrol Dial Transplant. 2002;17:1603–13.PubMedCrossRef
27.
go back to reference Shappell SB, Myrthil G, Fogo A. An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis. 1997;29:966–70.PubMedCrossRef Shappell SB, Myrthil G, Fogo A. An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis. 1997;29:966–70.PubMedCrossRef
28.
go back to reference Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529–42.PubMedCrossRef Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529–42.PubMedCrossRef
29.
go back to reference Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest. 2004;114:679–88.PubMed Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA, et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest. 2004;114:679–88.PubMed
30.
go back to reference Trouw LA, Seelen MA, Visseren R, Duijs JM, Benediktsson H, de Heer E, et al. Anti-C1q autoantibodies in murine lupus nephritis. Clin Exp Immunol. 2004;135:41–8.PubMedCrossRef Trouw LA, Seelen MA, Visseren R, Duijs JM, Benediktsson H, de Heer E, et al. Anti-C1q autoantibodies in murine lupus nephritis. Clin Exp Immunol. 2004;135:41–8.PubMedCrossRef
Metadata
Title
Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis
Authors
Takashi Takei
Mitsuyo Itabashi
Takahito Moriyama
Ari Shimizu
Yuki Tsuruta
Ayami Ochi
Kayu Nakayama
Chihiro Iwasaki
Keiko Uchida
Kosaku Nitta
Publication date
01-02-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0667-6

Other articles of this Issue 1/2013

Clinical and Experimental Nephrology 1/2013 Go to the issue